Significant Investment in Lung Research by the American Lung Association
American Lung Association invests in leading scientists researching lung disease and lung cancer
In a notable announcement, the American Lung Association, a leading organization dedicated to lung health, has committed $22 million to new research grants aimed at advancing the understanding, diagnosis, treatment, and prevention of lung diseases. This substantial funding is aimed at tackling the challenges faced by approximately 35 million Americans living with chronic lung diseases.
This investment goes further than just numbers. It supports 130 researchers across various institutions, focusing on innovative clinical research, strategic partnerships, and the ongoing efforts of the Airways Clinical Research Centers (ACRC) Network. Such collaborations are crucial for developing cutting-edge methods to identify, treat, and ultimately find cures for lung diseases, especially during a time when federal support for scientific research is dwindling.
Harold Wimmer, the President and CEO of the American Lung Association, emphasized the importance of research in improving lung health and saving lives. "Research is the foundation for every breakthrough that improves lung health and saves lives," he remarked. This statement illustrates the organization's unwavering commitment to bridge the funding gap brought on by the federal level funding cuts. By supporting innovative science, the American Lung Association is offering hope to millions who are at risk or already affected by lung disease.
Research Grants for Lung Health Initiatives
For the 2025–2026 funding cycle, the American Lung Association awarded grants through a diverse array of programs designed to enhance lung health. These initiatives include the American Lung Association/AAAAI Allergic Respiratory Diseases Award, the American Lung Association/ATS/CHEST Foundation Respiratory Health Equity Research Award, Catalyst Award, Emerging Respiratory Pathogens Award, and several others, each addressing specific aspects of lung health.
Highlighting Outstanding Researchers
Among those receiving funding, several projects stand out. Carla Concepcion, PhD, from Columbia University, has been awarded the Lung Cancer Discovery Award for her project aimed at enhancing SMARCA therapy for treating lung cancer. Her work seeks to adapt models to closely mimic aggressive lung cancer patterns, leveraging new treatment methodologies for better patient outcomes.
Another notable awardee, Stephen Mein, MD, from Beth Israel Deaconess Medical Center, received the Public Health & Public Policy Research Award. His study investigates the impact of the Inflation Reduction Act on access to inhalers, particularly for Black and Hispanic adults suffering from asthma and COPD, illuminating critical health disparities.
Furthermore, Alison G. Lee, MD from the Icahn School of Medicine at Mount Sinai is exploring prenatal exposure to indoor air pollution. Her project, funded by the Indoor Air Award, tracks pregnant women's experiences and their infants' lung development to identify links between air quality and health outcomes.
A Rigorously Reviewed Selection Process
Each research project funded by the American Lung Association is subjected to a stringent scientific peer-review process. This ensures that only the most innovative, effective, and promising research initiatives receive financial support. In addition to funding individual researchers, the American Lung Association also invests in the ACRC Network, which stands as the largest nonprofit network focused on clinical research in asthma and COPD treatment.
Ongoing Commitment to Lung Health
The American Lung Association is currently accepting applications for its 2026–2027 research awards and grants cycle, encouraging researchers and institutions to contribute to this vital work. Those interested can find further details about current funding opportunities through the organization’s official website.
In summary, the American Lung Association is profoundly dedicated to enhancing lung health and combating lung disease through robust research funding and support for scientific innovation. This commitment not only helps advance our understanding of lung health but also plays a crucial role in impacting the lives of millions nationwide.
Frequently Asked Questions
What is the purpose of the $22 million investment by the American Lung Association?
The investment aims to advance research in understanding, diagnosing, treating, and preventing lung diseases, reaching many people affected.
Who are some of the researchers receiving grants?
Researchers include Carla Concepcion, Stephen Mein, and Alison G. Lee, focusing on diverse and impactful projects in lung health.
How does the American Lung Association select projects for funding?
Projects undergo a strict peer-review process ensuring funding is awarded to the most promising and innovative research initiatives.
Are there future funding opportunities with the American Lung Association?
Yes, the organization is currently accepting applications for its upcoming 2026–2027 research cycle.
What are the strategic imperatives of the American Lung Association?
The ALA focuses on defeating lung cancer, advocating for clean air, improving life quality for those with lung disease, and creating a tobacco-free future.
